Pfizer Covid-19 vaccine effectiveness upgraded in final analysis

BACK

Responsive image
18-11-2020

Pfizer have announced that the final analysis of the trials of its Covid vaccine in 44,000 people have shown it to be effective in over 94% of those over 65. This follows on the positive results of the Moderna vaccine and the results from the Astra Zenica/Oxford vaccine are expected to be released soon.